Kiadis-Kenner schreef op 1 augustus 2019 06:30:
Kiadis Pharma Netherlands B.V.; adjunctive treatment in haematopoietic stem cell
transplantation (HSCT) for a malignant disease
Scope: ad-hoc expert group meeting to take place on 3 September 2019. Update on the draft
list of experts.
Action: for information
List of Outstanding Issues adopted on 21.06.2019, 14.09.2018, 25.05.2018. List of Questions
adopted on 08.09.2017.